These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3124365)

  • 21. A serological comparison of Pasteurella haemolytica vaccines containing different adjuvants.
    Wells PW; Gilmour NJ; Burrells C; Thompson DA
    Res Vet Sci; 1979 Sep; 27(2):248-50. PubMed ID: 523817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dependence for reactivation of lipid-depleted Ca2+-ATPase of sarcoplasmic reticulum by non-ionic detergents on their hydrophile/lipophile balance.
    Melgunov VI; Akimova EI
    FEBS Lett; 1980 Dec; 121(2):235-8. PubMed ID: 6450687
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.
    Jiskoot W; Teerlink T; Van Hoof MM; Bartels K; Kanhai V; Crommelin DJ; Beuvery EC
    Infect Immun; 1986 Nov; 54(2):333-8. PubMed ID: 3095239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction of the DNA vaccine of major outer membrane protein of Neisseria gonorrhoeae and investigation of immune effects after vaccination].
    Liao F; He C; Liu HP; Song QF; Yan J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Nov; 40(6):422-6. PubMed ID: 17313744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fusion of hen erythrocytes by lipid-soluble and surface-active immunological adjuvants.
    Ahkong QF; Howell JI; Tampion W; Lucy JA
    FEBS Lett; 1974 May; 41(2):206-10. PubMed ID: 4137268
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of the adjuvant power of lipopolysaccharides of gram-negative bacteria and the corresponding lipid fractions in the mouse].
    Creach O; Gaja R; Fontanges R
    Ann Inst Pasteur (Paris); 1968 Jun; 114(6):786-95. PubMed ID: 5760430
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of non-ionic detergents for extraction and ion-exchange high-performance liquid chromatography of Sendai virus integral membrane proteins.
    Van Ede J; Nijmeijer JR; Welling-Wester S; Orvell C; Welling GW
    J Chromatogr; 1989 Aug; 476():319-27. PubMed ID: 2550495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100.
    Idänpään-Heikkilä I; Wahlström E; Muttilainen S; Nurminen M; Käyhty H; Sarvas M; Mäkelä PH
    Vaccine; 1996 Jun; 14(9):886-91. PubMed ID: 8843630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity.
    Latz E; Franko J; Golenbock DT; Schreiber JR
    J Immunol; 2004 Feb; 172(4):2431-8. PubMed ID: 14764714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein.
    Einhorn MS; Weinberg GA; Anderson EL; Granoff PD; Granoff DM
    Lancet; 1986 Aug; 2(8502):299-302. PubMed ID: 2874327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.
    Rosenqvist E; Høiby EA; Bjune G; Bryn K; Closs O; Feiring B; Klem A; Nøkleby H; Frølm LO
    NIPH Ann; 1991 Dec; 14(2):169-79; discussion 180-1. PubMed ID: 1687481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice.
    Katz D; Lehrer S; Galan O; Lachmi BE; Cohen S
    FEMS Microbiol Immunol; 1991 Nov; 3(6):305-20. PubMed ID: 1812932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Wong VK; Quagliata R; Adler R; Kim KS
    Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.
    Ferrari G; Garaguso I; Adu-Bobie J; Doro F; Taddei AR; Biolchi A; Brunelli B; Giuliani MM; Pizza M; Norais N; Grandi G
    Proteomics; 2006 Mar; 6(6):1856-66. PubMed ID: 16456881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improved method for the isolation of the major protein of the gonococcal outer membrane in an antigenically reactive form.
    James LT; Heckels JE
    J Immunol Methods; 1981; 42(2):223-8. PubMed ID: 6787136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control.
    Brewer JM; Alexander J
    Vaccine; 1994 May; 12(7):613-9. PubMed ID: 8085378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.